
Why are we still crossing joints to fix small-bone fractures? On this week’s MedTech Jam Session with Chris & Mike D, CEO Sarah Sachinis explains how Meduloc uses flexible nitinol to deliver intramedullary fixation without traversing the joint. This winning combination features elasticity (micromotion for healing) with distal locking for stability… All while protecting the joint. Genius! Meduloc, A Cor Medical Ventures portfolio company, benefitted greatly from the venture studio model as they shortened time to market and remained incredibly capital efficient. Check out our convo with Sarah on Apple, Spotify, or wherever you listen to podcasts. Powered by ConveyMED. To learn more about Meduloc, click here